n(g),n(g')-dimethyl-l-arginine has been researched along with Disease Models, Animal in 88 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Excerpt | Relevance | Reference |
---|---|---|
" A decrease in nitric oxide levels was reported in different hypertension models associated with increased concentrations of asymmetric dimethylarginine (ADMA) and homocysteine, and we recently described an increase in arginase type II expression under hypoxia." | 9.12 | Activation of arginase II by asymmetric dimethylarginine and homocysteine in hypertensive rats induced by hypoxia: a new model of nitric oxide synthesis regulation in hypertensive processes? ( López, V; Moraga, FA; Uribe, E, 2021) |
"Hyperhomocysteinemia is a risk factor for cardiovascular disease and stroke." | 8.82 | ADMA and hyperhomocysteinemia. ( Dayal, S; Lentz, SR, 2005) |
" The aim of this work was to characterize alterations in metabolites of the arginine pathway, energy metabolism, and structural and signalling lipids in plasma in the early and late stages of murine breast cancer metastasis." | 7.88 | Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics. ( Chlopicki, S; Jasztal, A; Kij, A; Kus, K; Stojak, M; Walczak, M; Zakrzewska, A, 2018) |
"The study aimed to investigate the protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats (SHRs) through the Cys-C/Wnt signaling pathway." | 7.85 | Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway. ( Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ, 2017) |
"The present study was designed to investigate whether oxymatrine could attenuate isoproterenol-induced heart failure via regulation of asymmetric dimethylarginine (ADMA) metabolism in rats." | 7.80 | Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats. ( Dai, G; Liu, J; Liu, YK; Wang, X; Wang, Y; Xu, Q; Xu, X; Zhang, J; Zhang, W, 2014) |
"Availability of L-arginine, the exclusive substrate for nitric oxide synthases, plays an important role in kidney ischemia/reperfusion injury." | 7.79 | Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. ( Betz, B; Böger, RH; Kniepert, J; Kress, T; Möller-Ehrlich, K; Sauvant, C; Schneider, R; Schwedhelm, E; Wanner, C, 2013) |
": This study aimed to investigate the effects of salvianolic acid A (Sal A) on the time course of plasma and tissue dimethylarginine levels after myocardial infarction (MI) induced by left coronary artery ligation." | 7.79 | Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction. ( He, H; Jiang, H; Li, X; Liu, X; Liu, Y; Wang, H; Wang, S; Yuan, L; Zhang, W, 2013) |
"Altered arginine metabolism, the uncoupling of nitric oxide synthase (NOS) by asymmetric dimethyl-arginine (ADMA), increased oxo-nitrosative stress, and cellular injury were reported in airway epithelial cells in asthma." | 7.77 | Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. ( Agrawal, A; Ahmad, T; Aich, J; Ghosh, B; Mabalirajan, U; Makhija, L; Sharma, A, 2011) |
"To investigate the levels of nitric oxide (NO) and asymmetric dimethylarginine (ADMA) in all the rat endometriosis models." | 7.77 | The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model. ( Akgul, EO; Aydin, I; Bilgi, C; Cakir, E; Cayci, T; Ceyhan, TS; Erbil, KM; Kurt, YG; Onguru, O; Yaman, H; Yasar, M, 2011) |
"To observe the effect of Xuefu Zhuyu decoction on serum asymmetric dimethylarginine (ADMA) level of the atherosclerosis rabbits." | 7.75 | [Effects of Xuefu Zhuyu decoction on serum asymmetric dimethylarginine in atherosclerosis rabbits]. ( Jiang, H; Li, Y; Lin, G; Zeng, H; Zhao, A, 2009) |
"Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, has been proposed to be a mediator of vascular dysfunction during hyperhomocysteinemia." | 7.74 | Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. ( Arning, E; Bottiglieri, T; Cooke, JP; Dayal, S; Faraci, FM; Kimoto, M; Lentz, SR; Murry, DJ; Rodionov, RN, 2008) |
"Melatonin is an antioxidant; however, its role in MTX neuropathy is not well studied." | 5.56 | Melatonin rescued methotrexate-induced spatial deficit and hyperhomocysteinemia and increased asymmetric dimethylarginine in plasma and dorsal hippocampus in developing rats. ( Chen, YC; Hsiao, CC; Hsu, MH; Huang, LT; Sheen, JM; Wang, SC, 2020) |
" Our results suggest that ADMA and oxidative stress likely reduce NO bioavailability under altitude hypoxia, which implies greater pulmonary vascular reactivity and tone, despite the more subdued effects observed under CIH." | 5.43 | Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension? ( Arriaza, K; Böger, RH; Brito, J; Klose, H; Leon-Velarde, F; Lüneburg, N; Pena, E; Siques, P, 2016) |
"Cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) is characterized by the severe constriction of an artery, which often leads to unfavorable outcomes." | 5.42 | Effect of 18β-glycyrrhetinic acid on cerebral vasospasm caused by asymmetric dimethylarginine after experimental subarachnoid hemorrhage in rats. ( He, X; Ji, Y; Lei, T; Liu, Q; Tian, W; Wang, G; Wang, Y; Xu, H; Zhao, D, 2015) |
"Proteinuria is an independent risk factor for cardiovascular disease (CVD) in patients with chronic kidney disease (CKD)." | 5.38 | Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome. ( Ando, R; Fukami, K; Iwatani, R; Kaida, Y; Nakayama, Y; Okuda, S; Ueda, S; Yamagishi, S, 2012) |
"Treatment with ramipril significantly reduced AV(BS) and improved aortic valve :outflow tract flow velocity ratio." | 5.37 | Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. ( Horowitz, JD; Kelly, DJ; Kennedy, JA; Ngo, DT; Qi, W; Smith, MD; Stafford, I; Sverdlov, AL; Weedon, H; Wuttke, RD; Zhang, Y, 2011) |
"Asymmetric dimethylarginine (ADMA) is an endogenous modulator of endothelial function and oxidative stress, and increased levels of this molecule have been reported in some metabolic disorders and cardiovascular diseases." | 5.37 | Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome. ( Collin, B; Cottin, Y; Duvillard, L; Goirand, F; Guilland, JC; Korandji, C; Lauzier, B; Moreau, D; Rochette, L; Sicard, P; Vergely, C; Zeller, M, 2011) |
"Allergen-induced lung inflammation was potentiated in mice with elevated circulating ADMA and was reduced in mice overexpressing DDAH." | 5.36 | Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. ( Buford, MC; Holian, A; Klein, E; Weigel, J; Wells, SM, 2010) |
" A decrease in nitric oxide levels was reported in different hypertension models associated with increased concentrations of asymmetric dimethylarginine (ADMA) and homocysteine, and we recently described an increase in arginase type II expression under hypoxia." | 5.12 | Activation of arginase II by asymmetric dimethylarginine and homocysteine in hypertensive rats induced by hypoxia: a new model of nitric oxide synthesis regulation in hypertensive processes? ( López, V; Moraga, FA; Uribe, E, 2021) |
"Hyperhomocysteinemia is a risk factor for cardiovascular disease and stroke." | 4.82 | ADMA and hyperhomocysteinemia. ( Dayal, S; Lentz, SR, 2005) |
" The aim of this work was to characterize alterations in metabolites of the arginine pathway, energy metabolism, and structural and signalling lipids in plasma in the early and late stages of murine breast cancer metastasis." | 3.88 | Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics. ( Chlopicki, S; Jasztal, A; Kij, A; Kus, K; Stojak, M; Walczak, M; Zakrzewska, A, 2018) |
" In contrast, cDDAH1 KO mice exposed to TAC showed no increase in LV DDAH1 expression, slightly increased LV tissue ADMA levels, no increase in plasma ADMA, but significantly exacerbated LV hypertrophy, fibrosis, nitrotyrosine production, and LV dysfunction." | 3.85 | Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction. ( Atzler, D; Böger, RH; Chen, P; Chen, Y; Fassett, J; Guo, H; Hu, X; Kwak, D; Liu, X; Lu, Z; Schwedhelm, E; Wang, H; Xu, X; Yue, W; Zhang, P, 2017) |
"The study aimed to investigate the protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats (SHRs) through the Cys-C/Wnt signaling pathway." | 3.85 | Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway. ( Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ, 2017) |
"The purpose of the work was to study the impact of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) and its degrading enzyme, dimethylarginine dimethylaminohydrolase (DDAH1), on atherosclerosis in subtotally nephrectomized (SNX) ApoE-deficient mice." | 3.80 | Effect of lowering asymmetric dimethylarginine (ADMA) on vascular pathology in atherosclerotic ApoE-deficient mice with reduced renal mass. ( Arend, M; Cordasic, N; Hilgers, KF; Jacobi, J; Maas, R, 2014) |
"The present study was designed to investigate whether oxymatrine could attenuate isoproterenol-induced heart failure via regulation of asymmetric dimethylarginine (ADMA) metabolism in rats." | 3.80 | Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats. ( Dai, G; Liu, J; Liu, YK; Wang, X; Wang, Y; Xu, Q; Xu, X; Zhang, J; Zhang, W, 2014) |
": This study aimed to investigate the effects of salvianolic acid A (Sal A) on the time course of plasma and tissue dimethylarginine levels after myocardial infarction (MI) induced by left coronary artery ligation." | 3.79 | Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction. ( He, H; Jiang, H; Li, X; Liu, X; Liu, Y; Wang, H; Wang, S; Yuan, L; Zhang, W, 2013) |
"A low concentration of nitric oxide associated with a high concentration of asymmetric dimethylarginine (ADMA) can explain the lack of ischemic cardioprotection observed in the presence of hypercholesterolemia." | 3.79 | High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats. ( Casella-Filho, A; Chagas, AC; da-Luz, PL; Dourado, PM; Landim, MB, 2013) |
"Availability of L-arginine, the exclusive substrate for nitric oxide synthases, plays an important role in kidney ischemia/reperfusion injury." | 3.79 | Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. ( Betz, B; Böger, RH; Kniepert, J; Kress, T; Möller-Ehrlich, K; Sauvant, C; Schneider, R; Schwedhelm, E; Wanner, C, 2013) |
"Altered arginine metabolism, the uncoupling of nitric oxide synthase (NOS) by asymmetric dimethyl-arginine (ADMA), increased oxo-nitrosative stress, and cellular injury were reported in airway epithelial cells in asthma." | 3.77 | Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. ( Agrawal, A; Ahmad, T; Aich, J; Ghosh, B; Mabalirajan, U; Makhija, L; Sharma, A, 2011) |
"To investigate the levels of nitric oxide (NO) and asymmetric dimethylarginine (ADMA) in all the rat endometriosis models." | 3.77 | The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model. ( Akgul, EO; Aydin, I; Bilgi, C; Cakir, E; Cayci, T; Ceyhan, TS; Erbil, KM; Kurt, YG; Onguru, O; Yaman, H; Yasar, M, 2011) |
" We found that mild hypertension, increased plasma levels of creatinine, inorganic phosphate, asymmetric dimethylarginine (ADMA), and parathyroid hormone (PTH) were observed in the present SNx rats without LVH." | 3.77 | Left ventricular hypertrophy is associated with inflammation in sodium loaded subtotal nephrectomized rats. ( Aizawa, K; Ishizuka, N; Iwabuchi, S; Kitamura, H; Moriguchi, Y; Nishimura, T; Serizawa, K; Tashiro, Y; Yogo, K; Yorozu, K, 2011) |
" The gastric tissues were collected for determination of the gastric ulcer index, asymmetric dimethylarginine (ADMA) and nitric oxide (NO) contents, the activity of dimethylarginine dimethylaminohydrolase (DDAH) and superoxide anion (O2(-)) or hydroxyl radical (OH*) formation." | 3.76 | The role of the DDAH-ADMA pathway in the protective effect of resveratrol analog BTM-0512 on gastric mucosal injury. ( Li, L; Liu, YZ; Luo, XJ; Peng, J; Tan, N; Xiang, DX; Yuan, Q; Zhang, YS, 2010) |
"To observe the effect of Xuefu Zhuyu decoction on serum asymmetric dimethylarginine (ADMA) level of the atherosclerosis rabbits." | 3.75 | [Effects of Xuefu Zhuyu decoction on serum asymmetric dimethylarginine in atherosclerosis rabbits]. ( Jiang, H; Li, Y; Lin, G; Zeng, H; Zhao, A, 2009) |
"Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, has been proposed to be a mediator of vascular dysfunction during hyperhomocysteinemia." | 3.74 | Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. ( Arning, E; Bottiglieri, T; Cooke, JP; Dayal, S; Faraci, FM; Kimoto, M; Lentz, SR; Murry, DJ; Rodionov, RN, 2008) |
"Melatonin is an antioxidant; however, its role in MTX neuropathy is not well studied." | 1.56 | Melatonin rescued methotrexate-induced spatial deficit and hyperhomocysteinemia and increased asymmetric dimethylarginine in plasma and dorsal hippocampus in developing rats. ( Chen, YC; Hsiao, CC; Hsu, MH; Huang, LT; Sheen, JM; Wang, SC, 2020) |
"Hemorrhagic shock was induced by bleeding the animals." | 1.48 | Time-Dependent Production of Endothelium-Related Biomarkers is Affected Differently in Hemorrhagic and Septic Shocks. ( Coskun, CN; Demirel-Yilmaz, E; Savci, V; Usanmaz, SE, 2018) |
" Our results suggest that ADMA and oxidative stress likely reduce NO bioavailability under altitude hypoxia, which implies greater pulmonary vascular reactivity and tone, despite the more subdued effects observed under CIH." | 1.43 | Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension? ( Arriaza, K; Böger, RH; Brito, J; Klose, H; Leon-Velarde, F; Lüneburg, N; Pena, E; Siques, P, 2016) |
"Cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) is characterized by the severe constriction of an artery, which often leads to unfavorable outcomes." | 1.42 | Effect of 18β-glycyrrhetinic acid on cerebral vasospasm caused by asymmetric dimethylarginine after experimental subarachnoid hemorrhage in rats. ( He, X; Ji, Y; Lei, T; Liu, Q; Tian, W; Wang, G; Wang, Y; Xu, H; Zhao, D, 2015) |
"Melatonin-treated rats received daily melatonin 1 mg/kg/d via i." | 1.39 | Melatonin regulates L-arginine transport and NADPH oxidase in young rats with bile duct ligation: role of protein kinase C. ( Chen, CC; Huang, LT; Kao, YH; Lee, CT; Sheen, JM; Tain, YL; Yu, HR, 2013) |
"Thirty five patients had persistent atrial fibrillation (AF)≥ 4months." | 1.38 | The impact of rapid atrial pacing on ADMA and endothelial NOS. ( Bode-Böger, SM; Bukowska, A; Dobrev, D; Goette, A; Hammwöhner, M; Lendeckel, U; Martens-Lobenhoffer, J; Medunjanin, S; Ravens, U; Scalera, F; Weinert, S, 2012) |
"The development of pulmonary hypertension is a common accompaniment of congenital heart disease (CHD) with increased pulmonary blood flow." | 1.38 | Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I. ( Aramburo, A; Black, SM; Fineman, JR; Kalkan, G; Kallarackal, S; Kumar, S; Rafikov, R; Rehmani, I; Sharma, S; Sun, X; Tian, J, 2012) |
"Proteinuria is an independent risk factor for cardiovascular disease (CVD) in patients with chronic kidney disease (CKD)." | 1.38 | Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome. ( Ando, R; Fukami, K; Iwatani, R; Kaida, Y; Nakayama, Y; Okuda, S; Ueda, S; Yamagishi, S, 2012) |
"Treatment with ramipril significantly reduced AV(BS) and improved aortic valve :outflow tract flow velocity ratio." | 1.37 | Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. ( Horowitz, JD; Kelly, DJ; Kennedy, JA; Ngo, DT; Qi, W; Smith, MD; Stafford, I; Sverdlov, AL; Weedon, H; Wuttke, RD; Zhang, Y, 2011) |
"Asymmetric dimethylarginine (ADMA) is an endogenous modulator of endothelial function and oxidative stress, and increased levels of this molecule have been reported in some metabolic disorders and cardiovascular diseases." | 1.37 | Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome. ( Collin, B; Cottin, Y; Duvillard, L; Goirand, F; Guilland, JC; Korandji, C; Lauzier, B; Moreau, D; Rochette, L; Sicard, P; Vergely, C; Zeller, M, 2011) |
"Melatonin-treated BDL rats received daily melatonin 1 mg/kg/day via intraperitoneal injection." | 1.36 | Melatonin prevents increased asymmetric dimethylarginine in young rats with bile duct ligation. ( Chen, CC; Hsieh, CS; Huang, LT; Lee, CT; Sheen, JM; Tain, YL, 2010) |
"Allergen-induced lung inflammation was potentiated in mice with elevated circulating ADMA and was reduced in mice overexpressing DDAH." | 1.36 | Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. ( Buford, MC; Holian, A; Klein, E; Weigel, J; Wells, SM, 2010) |
" Blood pressure and renal excretion were measured in adulthood, under different sodium conditions, and before and after chronic administration of either N(G)-nitro-l-arginine methyl ester (l-NAME) or l-arginine." | 1.35 | Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals. ( Brown, RD; Carlström, M; Edlund, J; Larsson, E; Palm, F; Persson, AE; Sällström, J; Teerlink, T; Wåhlin, N, 2008) |
"Hindlimb ischemia was surgically induced in C57BL/6J mice, apo E-deficient mice, or transgenic mice overexpressing dimethylarginine dimethylaminohydrolase (DDAH)." | 1.33 | ADMA regulates angiogenesis: genetic and metabolic evidence. ( Achan, V; Cooke, JP; Heeschen, C; Ho, HK; Jang, JJ; Kimoto, M; Stuehlinger, M; Vallance, P, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 23 (26.14) | 29.6817 |
2010's | 61 (69.32) | 24.3611 |
2020's | 4 (4.55) | 2.80 |
Authors | Studies |
---|---|
Chen, YC | 2 |
Sheen, JM | 4 |
Hsu, MH | 1 |
Hsiao, CC | 1 |
Wang, SC | 1 |
Huang, LT | 4 |
Hu, W | 1 |
Wang, W | 1 |
Ma, Q | 1 |
Liu, T | 1 |
Zhang, J | 3 |
Wu, M | 1 |
Yuan, M | 1 |
Wang, Y | 4 |
Tan, B | 1 |
Huang, D | 1 |
Wang, C | 1 |
Zou, Y | 1 |
Ye, C | 1 |
López, V | 1 |
Uribe, E | 1 |
Moraga, FA | 1 |
Tain, YL | 4 |
Hsu, CN | 1 |
Shi, L | 1 |
Zhao, C | 1 |
Wang, H | 3 |
Lei, T | 2 |
Liu, S | 1 |
Cao, J | 1 |
Lu, Z | 3 |
Xu, X | 3 |
Zhang, P | 2 |
Kwak, D | 1 |
Fassett, J | 1 |
Yue, W | 2 |
Atzler, D | 1 |
Hu, X | 2 |
Liu, X | 2 |
Guo, H | 1 |
Schwedhelm, E | 2 |
Böger, RH | 4 |
Chen, P | 1 |
Chen, Y | 3 |
Janić, M | 2 |
Lunder, M | 2 |
France Štiglic, A | 1 |
Jerin, A | 2 |
Skitek, M | 2 |
Černe, D | 2 |
Marc, J | 2 |
Drevenšek, G | 2 |
Šabovič, M | 2 |
Coskun, CN | 1 |
Usanmaz, SE | 2 |
Savci, V | 1 |
Demirel-Yilmaz, E | 2 |
Xiao, HB | 1 |
Sui, GG | 1 |
Lu, XY | 1 |
Sun, ZL | 1 |
Pang, P | 1 |
Abbott, M | 1 |
Abdi, M | 1 |
Fucci, QA | 1 |
Chauhan, N | 1 |
Mistri, M | 1 |
Proctor, B | 1 |
Chin, M | 1 |
Wang, B | 1 |
Yin, W | 1 |
Lu, TS | 1 |
Halim, A | 1 |
Lim, K | 1 |
Handy, DE | 1 |
Loscalzo, J | 1 |
Siedlecki, AM | 1 |
Verkaik, M | 1 |
Juni, RP | 1 |
van Loon, EPM | 1 |
van Poelgeest, EM | 1 |
Kwekkeboom, RFJ | 1 |
Gam, Z | 1 |
Richards, WG | 1 |
Ter Wee, PM | 1 |
Hoenderop, JG | 1 |
Eringa, EC | 1 |
Vervloet, MG | 1 |
Dovinová, I | 1 |
Hrabárová, E | 1 |
Jansen, E | 1 |
Kvandová, M | 1 |
Majzúnová, M | 1 |
Berenyiová, A | 1 |
Barančík, M | 1 |
Kus, K | 1 |
Kij, A | 1 |
Zakrzewska, A | 1 |
Jasztal, A | 1 |
Stojak, M | 1 |
Walczak, M | 1 |
Chlopicki, S | 1 |
Takahashi, K | 2 |
Ueda, S | 6 |
Kobayashi, T | 1 |
Nishiyama, A | 1 |
Fujisawa, Y | 1 |
Sugaya, T | 1 |
Shiota, S | 1 |
Gohda, T | 1 |
Horikoshi, S | 1 |
Suzuki, Y | 1 |
He, H | 1 |
Li, X | 1 |
Zhang, W | 3 |
Jiang, H | 2 |
Wang, S | 1 |
Yuan, L | 1 |
Liu, Y | 1 |
Karaaslan, O | 1 |
Sonmez, E | 1 |
Kankaya, Y | 1 |
Silistreli, OK | 1 |
Can, MM | 1 |
Bedir, YK | 1 |
Caliskan, G | 1 |
Landim, MB | 1 |
Dourado, PM | 1 |
Casella-Filho, A | 1 |
Chagas, AC | 1 |
da-Luz, PL | 1 |
Betz, B | 1 |
Möller-Ehrlich, K | 1 |
Kress, T | 1 |
Kniepert, J | 1 |
Wanner, C | 1 |
Sauvant, C | 1 |
Schneider, R | 1 |
Ghebremariam, YT | 1 |
LePendu, P | 1 |
Lee, JC | 1 |
Erlanson, DA | 1 |
Slaviero, A | 1 |
Shah, NH | 1 |
Leiper, J | 1 |
Cooke, JP | 6 |
Pacurari, M | 1 |
Xing, D | 1 |
Hilgers, RH | 1 |
Guo, YY | 1 |
Yang, Z | 1 |
Hage, FG | 1 |
Han, X | 1 |
Zhang, DL | 1 |
Yin, DX | 1 |
Zhang, QD | 1 |
Liu, WH | 1 |
Aggarwal, S | 2 |
Gross, CM | 1 |
Kumar, S | 4 |
Dimitropoulou, C | 1 |
Sharma, S | 4 |
Gorshkov, BA | 1 |
Sridhar, S | 1 |
Lu, Q | 3 |
Bogatcheva, NV | 1 |
Jezierska-Drutel, AJ | 1 |
Lucas, R | 1 |
Verin, AD | 1 |
Catravas, JD | 2 |
Black, SM | 5 |
Jacobi, J | 1 |
Maas, R | 4 |
Arend, M | 1 |
Cordasic, N | 1 |
Hilgers, KF | 1 |
Rodionov, RN | 3 |
Martens-Lobenhoffer, J | 2 |
Brilloff, S | 1 |
Hohenstein, B | 1 |
Jarzebska, N | 1 |
Jabs, N | 1 |
Kittel, A | 1 |
Weiss, N | 1 |
Bode-Böger, SM | 2 |
Ferrigno, A | 3 |
Rizzo, V | 2 |
Bianchi, A | 1 |
Di Pasqua, LG | 2 |
Berardo, C | 2 |
Richelmi, P | 2 |
Vairetti, M | 3 |
Sasser, JM | 1 |
Cunningham, MW | 1 |
Baylis, C | 1 |
Liu, YK | 1 |
Liu, J | 1 |
Wang, X | 1 |
Xu, Q | 1 |
Dai, G | 1 |
Garcia-Martinez, R | 1 |
Andreola, F | 1 |
Mehta, G | 1 |
Poulton, K | 1 |
Oria, M | 1 |
Jover, M | 1 |
Soeda, J | 1 |
Macnaughtan, J | 1 |
De Chiara, F | 1 |
Habtesion, A | 1 |
Mookerjee, RP | 2 |
Davies, N | 1 |
Jalan, R | 2 |
Zhao, D | 1 |
Liu, Q | 1 |
Ji, Y | 1 |
Wang, G | 1 |
He, X | 1 |
Tian, W | 1 |
Xu, H | 1 |
Luo, Y | 1 |
Quan, X | 1 |
Zhao, B | 1 |
Magné, J | 1 |
Huneau, JF | 1 |
Borderie, D | 1 |
Mathé, V | 1 |
Bos, C | 1 |
Mariotti, F | 1 |
Greco, R | 1 |
Demartini, C | 1 |
Zanaboni, A | 1 |
Mangione, AS | 1 |
Blandini, F | 1 |
Nappi, G | 1 |
Tassorelli, C | 1 |
Sun, X | 4 |
Kellner, M | 1 |
Desai, AA | 1 |
Wang, T | 1 |
Kangath, A | 1 |
Qu, N | 1 |
Klinger, C | 1 |
Fratz, S | 3 |
Yuan, JX | 1 |
Jacobson, JR | 1 |
Garcia, JG | 1 |
Rafikov, R | 4 |
Fineman, JR | 4 |
Sun, L | 1 |
Bai, Y | 1 |
Zhao, R | 1 |
Sun, T | 1 |
Cao, R | 1 |
Wang, F | 1 |
He, G | 1 |
Ye, P | 1 |
Du, G | 1 |
Lüneburg, N | 2 |
Siques, P | 1 |
Brito, J | 1 |
Arriaza, K | 1 |
Pena, E | 1 |
Klose, H | 1 |
Leon-Velarde, F | 1 |
Croce, AC | 1 |
Feng, J | 1 |
Chen, HW | 1 |
Pi, LJ | 1 |
Wang, J | 1 |
Zhan, DQ | 1 |
Fassett, JT | 1 |
Zhu, G | 1 |
Li, J | 1 |
Bache, RJ | 1 |
Durmus, N | 1 |
Toylu, A | 1 |
Evcim, S | 1 |
Soner, BC | 1 |
Demir, O | 1 |
Kahraman, E | 1 |
Demir, T | 1 |
Irer, B | 1 |
Gidener, S | 1 |
Atabey, N | 1 |
Esen, A | 1 |
Dayal, S | 2 |
Arning, E | 1 |
Bottiglieri, T | 1 |
Kimoto, M | 3 |
Murry, DJ | 1 |
Faraci, FM | 1 |
Lentz, SR | 3 |
Shibata, R | 2 |
Yamagishi, S | 4 |
Kaida, Y | 3 |
Matsumoto, Y | 3 |
Fukami, K | 4 |
Hayashida, A | 1 |
Matsuoka, H | 2 |
Kato, S | 1 |
Okuda, S | 5 |
Fujimi-Hayashida, A | 1 |
Koike, K | 1 |
Tanaka, H | 1 |
Banday, AA | 1 |
Lokhandwala, MF | 1 |
Böger, R | 1 |
Nurten, T | 1 |
Nihal, S | 1 |
Gonca, O | 1 |
Ozgür, A | 1 |
Halil, Y | 1 |
Filiz, B | 1 |
Barbaros, B | 1 |
Li, Y | 1 |
Zhao, A | 1 |
Zeng, H | 1 |
Lin, G | 1 |
Hsieh, CS | 1 |
Chen, CC | 2 |
Lee, CT | 2 |
Li, L | 1 |
Luo, XJ | 1 |
Liu, YZ | 1 |
Zhang, YS | 1 |
Yuan, Q | 1 |
Tan, N | 1 |
Xiang, DX | 1 |
Peng, J | 1 |
Ahmad, T | 1 |
Mabalirajan, U | 1 |
Sharma, A | 1 |
Aich, J | 1 |
Makhija, L | 1 |
Ghosh, B | 1 |
Agrawal, A | 1 |
Hou, Y | 1 |
Rehmani, I | 2 |
Tian, J | 2 |
Smith, A | 1 |
Schreiber, C | 2 |
Reiser, J | 1 |
Naumann, S | 1 |
Haag, S | 1 |
Hess, J | 1 |
Patterson, C | 1 |
Klein, E | 1 |
Weigel, J | 1 |
Buford, MC | 1 |
Holian, A | 1 |
Wells, SM | 1 |
Goette, A | 1 |
Hammwöhner, M | 1 |
Bukowska, A | 1 |
Scalera, F | 1 |
Dobrev, D | 1 |
Ravens, U | 1 |
Weinert, S | 1 |
Medunjanin, S | 1 |
Lendeckel, U | 1 |
Ngo, DT | 1 |
Stafford, I | 1 |
Sverdlov, AL | 1 |
Qi, W | 1 |
Wuttke, RD | 1 |
Zhang, Y | 1 |
Kelly, DJ | 1 |
Weedon, H | 1 |
Smith, MD | 1 |
Kennedy, JA | 1 |
Horowitz, JD | 1 |
Korandji, C | 1 |
Zeller, M | 1 |
Guilland, JC | 1 |
Collin, B | 1 |
Lauzier, B | 1 |
Sicard, P | 1 |
Duvillard, L | 1 |
Goirand, F | 1 |
Moreau, D | 1 |
Cottin, Y | 1 |
Rochette, L | 1 |
Vergely, C | 1 |
Cayci, T | 1 |
Akgul, EO | 1 |
Kurt, YG | 1 |
Ceyhan, TS | 1 |
Aydin, I | 1 |
Onguru, O | 1 |
Yaman, H | 1 |
Cakir, E | 1 |
Yasar, M | 1 |
Bilgi, C | 1 |
Erbil, KM | 1 |
Moriguchi, Y | 1 |
Yogo, K | 1 |
Aizawa, K | 1 |
Serizawa, K | 1 |
Tashiro, Y | 1 |
Yorozu, K | 1 |
Ishizuka, N | 1 |
Iwabuchi, S | 1 |
Kitamura, H | 1 |
Nishimura, T | 1 |
Bugnicourt, JM | 1 |
Da Silveira, C | 1 |
Bengrine, A | 1 |
Godefroy, O | 1 |
Baumbach, G | 1 |
Sevestre, H | 1 |
Bode-Boeger, SM | 1 |
Kielstein, JT | 1 |
Massy, ZA | 1 |
Chillon, JM | 1 |
Li Volti, G | 1 |
Salomone, S | 1 |
Sorrenti, V | 1 |
Mangiameli, A | 1 |
Urso, V | 1 |
Siarkos, I | 1 |
Galvano, F | 1 |
Salamone, F | 1 |
Kleinedler, JJ | 1 |
Orchard, EA | 1 |
Foley, JD | 1 |
Rogers, LK | 1 |
Hebert, VY | 1 |
Dugas, TR | 1 |
Wilcox, CS | 1 |
Kajimoto, H | 1 |
Kai, H | 1 |
Aoki, H | 1 |
Yasuoka, S | 1 |
Anegawa, T | 1 |
Aoki, Y | 1 |
Imaizumi, T | 2 |
Sharma, V | 1 |
Ten Have, GA | 1 |
Ytrebo, L | 1 |
Sen, S | 1 |
Rose, CF | 1 |
Dalton, RN | 1 |
Turner, C | 1 |
Revhaug, A | 1 |
van-Eijk, HM | 1 |
Deutz, NE | 1 |
Davies, NA | 1 |
Northcott, CA | 1 |
Billecke, S | 1 |
Craig, T | 1 |
Hinojosa-Laborde, C | 1 |
Patel, KP | 1 |
Chen, AF | 1 |
D'Alecy, LG | 1 |
Haywood, JR | 1 |
Kimura, K | 1 |
Aramburo, A | 1 |
Kalkan, G | 1 |
Kallarackal, S | 1 |
Nakayama, Y | 1 |
Ando, R | 1 |
Iwatani, R | 1 |
Sirmagul, B | 1 |
Ilgin, S | 1 |
Atli, O | 1 |
Rafikova, O | 1 |
Burns, T | 1 |
Dasarathy, S | 1 |
Wright, J | 1 |
Radman, M | 1 |
Kao, YH | 1 |
Yu, HR | 1 |
Millatt, LJ | 1 |
Whitley, GS | 1 |
Li, D | 1 |
Leiper, JM | 1 |
Siragy, HM | 1 |
Carey, RM | 1 |
Johns, RA | 1 |
Dai, Z | 1 |
Zhu, HQ | 1 |
Jiang, DJ | 1 |
Jiang, JL | 1 |
Deng, HW | 1 |
Li, YJ | 1 |
Jung, CS | 1 |
Iuliano, BA | 1 |
Harvey-White, J | 1 |
Espey, MG | 1 |
Oldfield, EH | 1 |
Pluta, RM | 1 |
Pullamsetti, S | 1 |
Kiss, L | 1 |
Ghofrani, HA | 1 |
Voswinckel, R | 1 |
Haredza, P | 1 |
Klepetko, W | 1 |
Aigner, C | 1 |
Fink, L | 1 |
Muyal, JP | 1 |
Weissmann, N | 1 |
Grimminger, F | 1 |
Seeger, W | 1 |
Schermuly, RT | 1 |
Achan, V | 1 |
Ho, HK | 1 |
Heeschen, C | 1 |
Stuehlinger, M | 1 |
Jang, JJ | 1 |
Vallance, P | 1 |
Konishi, H | 1 |
Sydow, K | 1 |
Potena, L | 1 |
Ferrara, R | 1 |
Mocarski, ES | 1 |
Lewis, DB | 1 |
Grigioni, F | 1 |
Coccolo, F | 1 |
Magnani, G | 1 |
Fallani, F | 1 |
Magelli, C | 1 |
Valantine, HA | 1 |
Branzi, A | 1 |
Matsuguma, K | 1 |
Carlström, M | 1 |
Brown, RD | 1 |
Edlund, J | 1 |
Sällström, J | 1 |
Larsson, E | 1 |
Teerlink, T | 1 |
Palm, F | 1 |
Wåhlin, N | 1 |
Persson, AE | 1 |
Matrougui, K | 1 |
Loufrani, L | 1 |
Lévy, BI | 1 |
Henrion, D | 1 |
Masuda, H | 1 |
Tsujii, T | 1 |
Okuno, T | 1 |
Kihara, K | 1 |
Goto, M | 1 |
Azuma, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Adiposity and Airway Inflammation in HIV-Associated Airway Disease[NCT02975258] | 102 participants (Actual) | Observational | 2015-09-30 | Completed | |||
Phase 1 Study of the Safety and Pharmacokinetics of Perioperative IV L-carnitine Administration in Patients With Congenital Heart Disease With Increased Pulmonary Blood Flow[NCT01825369] | Phase 1 | 0 participants (Actual) | Interventional | 2014-12-31 | Withdrawn (stopped due to Changes to cardiac surgery program) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
11 reviews available for n(g),n(g')-dimethyl-l-arginine and Disease Models, Animal
Article | Year |
---|---|
Activation of arginase II by asymmetric dimethylarginine and homocysteine in hypertensive rats induced by hypoxia: a new model of nitric oxide synthesis regulation in hypertensive processes?
Topics: Animals; Arginase; Arginine; Disease Models, Animal; Homocysteine; Hypertension; Hypoxia; Nitric Oxi | 2021 |
Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Energy Metabolism; Humans; Nitri | 2017 |
Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.
Topics: Animals; Arginine; Bile Ducts; Disease Models, Animal; Fibrosis; Ligation; Liver; Liver Cirrhosis; M | 2014 |
ADMA and the role of the genes: lessons from genetically modified animals and human gene polymorphisms.
Topics: Animals; Animals, Genetically Modified; Arginine; Disease Models, Animal; Humans; Polymorphism, Gene | 2009 |
Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Humans; K | 2012 |
[Methylarginies-induced endothelial dysfunction in chronic kidney disease].
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Enzyme In | 2012 |
A novel mechanism for pulmonary arterial hypertension?
Topics: Amidohydrolases; Animals; Arginine; Disease Models, Animal; Humans; Hypertension, Pulmonary; Mice; N | 2003 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Dise | 2004 |
ADMA and hyperhomocysteinemia.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Va | 2005 |
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
Topics: Amidohydrolases; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; | 2005 |
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome].
Topics: Animals; Arginine; Clinical Trials as Topic; Coronary Disease; Cytomegalovirus Infections; Disease M | 2007 |
77 other studies available for n(g),n(g')-dimethyl-l-arginine and Disease Models, Animal
Article | Year |
---|---|
Melatonin rescued methotrexate-induced spatial deficit and hyperhomocysteinemia and increased asymmetric dimethylarginine in plasma and dorsal hippocampus in developing rats.
Topics: Animals; Animals, Newborn; Antimetabolites, Antineoplastic; Arginine; Disease Models, Animal; Hippoc | 2020 |
Blueberry anthocyanin‑enriched extract ameliorates transverse aortic constriction‑induced myocardial dysfunction via the DDAH1/ADMA/NO signaling pathway in mice.
Topics: Amidohydrolases; Animals; Anthocyanins; Aortic Valve Stenosis; Apoptosis; Arginine; Blueberry Plants | 2020 |
Renal asymmetric dimethylarginine inhibits fibrosis.
Topics: Amidohydrolases; Animals; Arginine; Disease Models, Animal; Fibronectins; Fibrosis; Kidney; Kidney D | 2020 |
Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.
Topics: Aging; Aldosterone; Amidohydrolases; Animals; Arginine; Cell Line; Creatinine; Diabetes Mellitus, Ex | 2017 |
Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Topics: Amidohydrolases; Animals; Arginine; Atrial Natriuretic Factor; Disease Models, Animal; Fibrosis; Gen | 2017 |
Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Cholest | 2017 |
Time-Dependent Production of Endothelium-Related Biomarkers is Affected Differently in Hemorrhagic and Septic Shocks.
Topics: Animals; Antioxidants; Arginine; Biomarkers; Blood Pressure; Disease Models, Animal; Endothelial Cel | 2018 |
Elevated Levels of ADMA Are Associated with Lower DDAH2 and Higher PRMT1 in LPS-Induced Endometritis Rats.
Topics: Amidohydrolases; Animals; Arginine; Dinoprost; Disease Models, Animal; Down-Regulation; Endometriosi | 2018 |
Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function.
Topics: Animals; Arginine; Disease Models, Animal; Glutathione Peroxidase; Heart Diseases; Mice; Mice, Knock | 2018 |
FGF23 impairs peripheral microvascular function in renal failure.
Topics: Animals; Arginine; Cells, Cultured; Coronary Circulation; Coronary Vessels; Disease Models, Animal; | 2018 |
ADMA, homocysteine and redox status improvement affected by 7-nitroindazole in spontaneously hypertensive rats.
Topics: Animals; Aorta; Arginine; Biomarkers; Disease Models, Animal; Enzyme Inhibitors; Heart Ventricles; H | 2018 |
Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
Topics: Animals; Arginase; Arginine; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Chromatography, | 2018 |
Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensins; Animals; Arginine; Cardiovascular Diseases; Deoxyguanosin | 2018 |
Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction.
Topics: Amidohydrolases; Animals; Arginine; Caffeic Acids; Chromatography, High Pressure Liquid; Creatinine; | 2013 |
Monitorization of asymmetric dimethylarginine (ADMA) levels in an experimental ischemia-reperfusion flap model: a preliminary report.
Topics: Abdominal Muscles; Animals; Arginine; Disease Models, Animal; Graft Rejection; Graft Survival; Male; | 2013 |
High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.
Topics: Animals; Arginine; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Hypercholesterolemia; | 2013 |
Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Topics: Acute Kidney Injury; Amidohydrolases; Animals; Arginine; Blotting, Western; Chromatography, High Pre | 2013 |
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Cells, Cultured; Disease Mo | 2013 |
Endothelial cell transfusion ameliorates endothelial dysfunction in 5/6 nephrectomized rats.
Topics: Acetylcholine; Amidohydrolases; Animals; Aorta; Arginine; Disease Models, Animal; Endothelial Cells; | 2013 |
Apelin-13 deteriorates hypertension in rats after damage of the vascular endothelium by ADMA.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Endothe | 2013 |
Dimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury.
Topics: Acute Lung Injury; Amidohydrolases; Animals; Arginine; Bronchoalveolar Lavage Fluid; Capillary Perme | 2014 |
Effect of lowering asymmetric dimethylarginine (ADMA) on vascular pathology in atherosclerotic ApoE-deficient mice with reduced renal mass.
Topics: Amidohydrolases; Animals; Aorta; Apolipoproteins E; Arginine; Atherosclerosis; Disease Models, Anima | 2014 |
Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomy.
Topics: Acute Kidney Injury; Alanine; Animals; Arginine; Biomarkers; Blotting, Western; Disease Models, Anim | 2014 |
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile.
Topics: Amidohydrolases; Animals; Arginine; Bile; Cationic Amino Acid Transporter 2; Disease Models, Animal; | 2014 |
Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Arginine; Arterial Pressure; Dinopro | 2014 |
Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats.
Topics: Alkaloids; Amidohydrolases; Animals; Arginine; Cardiotonic Agents; Disease Models, Animal; Female; H | 2014 |
Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure.
Topics: Albumins; Animals; Arginine; Disease Models, Animal; End Stage Liver Disease; Endothelium, Vascular; | 2015 |
Effect of 18β-glycyrrhetinic acid on cerebral vasospasm caused by asymmetric dimethylarginine after experimental subarachnoid hemorrhage in rats.
Topics: Animals; Arginine; Basilar Artery; Blotting, Western; Connexin 43; Connexins; Disease Models, Animal | 2015 |
Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Arginine; Caenorha | 2015 |
Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
Topics: Amidohydrolases; Animals; Arginine; Cathepsin D; Disease Models, Animal; Endothelium, Vascular; Gene | 2015 |
Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.
Topics: Amidohydrolases; Animals; Arginine; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Mal | 2015 |
Asymmetric Dimethylarginine Stimulates Akt1 Phosphorylation via Heat Shock Protein 70-Facilitated Carboxyl-Terminal Modulator Protein Degradation in Pulmonary Arterial Endothelial Cells.
Topics: Animals; Arginine; Carrier Proteins; Disease Models, Animal; Endothelial Cells; Genes, Dominant; HSP | 2016 |
The "Rise-Peak-Fall" Pattern of Time Dependency of the Cardiovascular Pleiotropic Effects of Treatment With Low-dose Atorvastatin, Losartan, and a Combination Thereof in Rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Arginine; Atorvastatin; Cardiovas | 2016 |
Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
Topics: Animals; Arginine; Carotid Artery Diseases; Carotid Artery Injuries; Cell Differentiation; Cell Move | 2016 |
Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?
Topics: Altitude Sickness; Amidohydrolases; Animals; Arginine; Disease Models, Animal; Hypertension, Pulmona | 2016 |
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters.
Topics: Amino Acid Transport Systems, Basic; Animals; Arginine; Choline; Disease Models, Animal; Fatty Liver | 2016 |
Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.
Topics: Abietanes; Animals; Arginine; Cardiomegaly; Cardiovascular Agents; Collagen Type I; Collagen Type I, | 2017 |
Repetitive ischemia increases myocardial dimethylarginine dimethylaminohydrolase 1 expression.
Topics: Amidohydrolases; Animals; Arginine; Cell Hypoxia; Cells, Cultured; Collateral Circulation; Coronary | 2017 |
Time-course changes of nLDL-induced erectile dysfunction.
Topics: Animals; Arginine; Disease Models, Animal; Endothelium, Vascular; Erectile Dysfunction; Hyperlipidem | 2017 |
Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Topics: Amidohydrolases; Animals; Arginine; Carotid Arteries; Cell Line; Cystathionine beta-Synthase; Diseas | 2008 |
Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
Topics: Adenoviridae; Amidohydrolases; Animals; Arginine; Diabetic Nephropathies; Disease Models, Animal; Ge | 2009 |
Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD).
Topics: Amidohydrolases; Animals; Arginine; Capillaries; Disease Models, Animal; Glomerulosclerosis, Focal S | 2009 |
Inhibition of natriuretic factors increases blood pressure in rats.
Topics: Amidohydrolases; Animals; Antioxidants; Arginine; Blood Pressure; Buthionine Sulfoximine; Cyclic N-O | 2009 |
Role of neutrophils in arginine-asymmetric dimethylarginine pathway subsequent to endotoxemia.
Topics: Animals; Arginine; Disease Models, Animal; Endotoxemia; Guinea Pigs; Lipopolysaccharides; Liver; Mal | 2009 |
[Effects of Xuefu Zhuyu decoction on serum asymmetric dimethylarginine in atherosclerosis rabbits].
Topics: Animals; Arginine; Atherosclerosis; Cholesterol; Disease Models, Animal; Drugs, Chinese Herbal; Huma | 2009 |
Melatonin prevents increased asymmetric dimethylarginine in young rats with bile duct ligation.
Topics: Amidohydrolases; Analysis of Variance; Animals; Arginine; Bile Ducts; Cholestasis, Intrahepatic; Dis | 2010 |
The role of the DDAH-ADMA pathway in the protective effect of resveratrol analog BTM-0512 on gastric mucosal injury.
Topics: Amidohydrolases; Animals; Anti-Ulcer Agents; Arginine; Disease Models, Animal; Ethanol; Hydroxyl Rad | 2010 |
Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma.
Topics: Airway Remodeling; Animals; Arginine; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Flui | 2011 |
C-terminus of heat shock protein 70-interacting protein-dependent GTP cyclohydrolase I degradation in lambs with increased pulmonary blood flow.
Topics: Animals; Anthracenes; Arginine; Blood Flow Velocity; Disease Models, Animal; Female; GTP Cyclohydrol | 2011 |
Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma.
Topics: Amidohydrolases; Animals; Arginine; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; En | 2010 |
The impact of rapid atrial pacing on ADMA and endothelial NOS.
Topics: Aged; Animals; Arginine; Atrial Fibrillation; Calcium-Binding Proteins; Disease Models, Animal; Endo | 2012 |
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve; Aortic Valve Stenosis; Arginine; Ca | 2011 |
Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome.
Topics: Animals; Aorta; Arginine; Blood Glucose; Blood Pressure; Body Weight; Disease Models, Animal; Dose-R | 2011 |
The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Disease Models, Animal; Endometriosis; F | 2011 |
Left ventricular hypertrophy is associated with inflammation in sodium loaded subtotal nephrectomized rats.
Topics: Animals; Arginine; Creatinine; Disease Models, Animal; Fibrosis; Hypertension; Hypertrophy, Left Ven | 2011 |
Chronic renal failure alters endothelial function in cerebral circulation in mice.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Arginine; Arterioles; Blotting, Western; Caveolin | 2011 |
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice.
Topics: Acetylcholine; Animals; Antioxidants; Aorta; Arginine; Diabetes Mellitus; Disease Models, Animal; En | 2011 |
A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting.
Topics: Angioplasty, Balloon; Animals; Arginine; Biomarkers; Carotid Arteries; Carotid Artery Injuries; Caro | 2011 |
Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Disease Models, Animal; Endothelium, Vascular; Human Umbilical V | 2012 |
Nitric oxide and L-arginine metabolism in a devascularized porcine model of acute liver failure.
Topics: Animals; Arginase; Arginine; Citrulline; Disease Models, Animal; Female; Liver; Liver Failure, Acute | 2012 |
Nitric oxide synthase, ADMA, SDMA, and nitric oxide activity in the paraventricular nucleus throughout the etiology of renal wrap hypertension.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Hypertension, Renal; K | 2012 |
Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I.
Topics: Acetylcarnitine; Adaptor Proteins, Signal Transducing; Animals; Animals, Newborn; Arginine; Biopteri | 2012 |
Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome.
Topics: Acetylcysteine; Animals; Antioxidants; Arginine; Cells, Cultured; Disease Models, Animal; Doxorubici | 2012 |
Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.
Topics: Animals; Aorta, Thoracic; Arginine; Disease Models, Animal; Endothelium, Vascular; Hydrogen Sulfide; | 2013 |
Disruption of endothelial cell mitochondrial bioenergetics in lambs with increased pulmonary blood flow.
Topics: Adenosine Triphosphate; Animals; Arginine; Carnitine; Disease Models, Animal; Endothelial Cells; Hea | 2013 |
Melatonin regulates L-arginine transport and NADPH oxidase in young rats with bile duct ligation: role of protein kinase C.
Topics: Animals; Arginase; Arginine; Biological Transport; Cationic Amino Acid Transporter 1; Cholestasis, E | 2013 |
Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
Topics: Amidohydrolases; Animals; Arginine; Blotting, Western; Chronic Disease; Disease Models, Animal; Enzy | 2003 |
17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Topics: Analysis of Variance; Animals; Aorta, Thoracic; Arginine; Cholesterol, LDL; Disease Models, Animal; | 2004 |
Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Topics: Animals; Arginine; Disease Models, Animal; Enzyme Inhibitors; Macaca fascicularis; Middle Cerebral A | 2004 |
Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
Topics: Amidohydrolases; Animals; Arginine; Disease Models, Animal; Humans; Hypertension, Pulmonary; Isoenzy | 2005 |
ADMA regulates angiogenesis: genetic and metabolic evidence.
Topics: Animals; Arginine; Blotting, Western; Disease Models, Animal; Female; Hypercholesterolemia; Ischemia | 2005 |
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
Topics: Amidohydrolases; Animals; Arginine; Cell Proliferation; Disease Models, Animal; Endothelium, Vascula | 2007 |
Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
Topics: Amidohydrolases; Animals; Arginine; Capillaries; Chronic Disease; Disease Models, Animal; Disease Pr | 2007 |
Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Diuresis; Enzyme Inhibitors; Hydronephros | 2008 |
The homocysteine paradox.
Topics: Animals; Arginine; Cardiovascular Diseases; Cystatin C; Cystatins; Disease Models, Animal; Folic Aci | 2008 |
High NaCl intake decreases both flow-induced dilation and pressure-induced myogenic tone in resistance arteries from normotensive rats: involvement of cyclooxygenase-2.
Topics: Animals; Arginine; Blood Pressure; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inh | 2001 |
Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia.
Topics: Animals; Arginine; Calcium; Carbachol; Cholinergic Agonists; Cyclic GMP; Disease Models, Animal; Dos | 2002 |